Supraglottic Airway for Resuscitation Trial
Comparing Two Multicomponent Strategies To Promote Supraglottic Airway Implementation During Neonatal Resuscitation
Children's Hospital of Philadelphia
36,503 participants
Jan 1, 2026
INTERVENTIONAL
Conditions
Summary
This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.
Eligibility
Inclusion Criteria11
- Population 1: Hospital Staff
- Population 1a: Clinical providers and administrators who complete study questionnaires
- Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation
- Fluent in English
- Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer)
- Fluent in English
- Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation
- Fluent in English
- Inborn (not transferred to the hospital after birth)
- ≥34 weeks' gestation at birth, based on best obstetrical estimate
- Received PPV during neonatal resuscitation (as per provider's clinical assessment)
Exclusion Criteria4
- Population 1b: Clinical providers who participate in qualitative interviews
- Population 2: Patients who receive neonatal resuscitation at birth
- Congenital diaphragmatic hernia
- Airway anomalies
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Enhanced Standard of Care ("Enhanced") will include: Educational Materials and Outreach, Local Champions, Train the Trainer, Local Simulation Training, and SA Starter Packs.
Enhanced Standard of Care ("Enhanced-Plus") will include: Educational Materials and Outreach, Local Champions, Train the Trainer, Local Simulation Training, SA Starter Packs, and three additional intensive external facilitation components.
Locations(30)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07150923